Victory Capital Management Inc Celldex Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 8,150 shares of CLDX stock, worth $210,188. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,150

Previous 8,322 2.07%

Holding current value

$210,188

Previous $307,000 10.1%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$32.06 - $44.56 $5,514 - $7,664	-172 Reduced 2.07%	8,150 $276,000
Q2 2024 Aug 05, 2024	BUY	$32.76 - $42.56 $2,850 - $3,702	87 Added 1.06%	8,322 $307,000
Q1 2024 May 03, 2024	BUY	$35.22 - $51.88 $34,621 - $50,998	983 Added 13.55%	8,235 $345,000
Q4 2023 Feb 05, 2024	BUY	$22.61 - $40.65 $163,967 - $294,793	7,252 New	7,252 $287,000
Q4 2022 Feb 10, 2023	BUY	$27.78 - $45.38 $1,277 - $2,087	46 Added 0.91%	5,096 $227,000
Q4 2022 Feb 09, 2023	SELL	$27.78 - $45.38 $186,653 - $304,908	-6,719 Reduced 57.09%	5,050 $225,000
Q3 2022 Nov 02, 2022	SELL	$22.7 - $37.57 $157,038 - $259,909	-6,918 Reduced 37.02%	11,769 $331,000
Q2 2022 Aug 01, 2022	BUY	$20.5 - $37.33 $25,891 - $47,147	1,263 Added 7.25%	18,687 $504,000
Q1 2022 May 04, 2022	BUY	$27.64 - $39.32 $53,483 - $76,084	1,935 Added 12.49%	17,424 $532,000
Q4 2021 Feb 07, 2022	SELL	$35.68 - $56.27 $149,427 - $235,658	-4,188 Reduced 21.28%	15,489 $598,000
Q3 2021 Nov 02, 2021	SELL	$28.95 - $55.99 $100,051 - $193,501	-3,456 Reduced 14.94%	19,677 $1.06 Million
Q2 2021 Aug 03, 2021	SELL	$20.71 - $35.37 $75,218 - $128,463	-3,632 Reduced 13.57%	23,133 $774,000
Q1 2021 May 04, 2021	BUY	$16.19 - $29.91 $162,094 - $299,458	10,012 Added 59.76%	26,765 $551,000
Q4 2020 Feb 01, 2021	BUY	$14.99 - $22.75 $251,127 - $381,130	16,753 New	16,753 $294,000
Q2 2020 Aug 07, 2020	SELL	$1.61 - $13.41 $3,542 - $29,502	-2,200 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.55 - $3.07 $77 - $153	-50 Reduced 2.22%	2,200 $4,000
Q4 2019 Feb 04, 2020	BUY	$2.11 - $2.8 $957 - $1,271	454 Added 25.28%	2,250 $5,000
Q3 2019 Nov 12, 2019	BUY	$2.05 - $2.75 $3,681 - $4,939	1,796 New	1,796 $4,000

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.21B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Celldex Therapeutics, Inc. Transaction History